key: cord-0060558-jjm9gz8i
authors: Mangalesh, Sridhar; Dudani, Sharmila; Malik, Ajay
title: Platelet Indices and Their Kinetics Predict Mortality in Patients of Sepsis
date: 2021-03-24
journal: Indian J Hematol Blood Transfus
DOI: 10.1007/s12288-021-01411-2
sha: 4ed5e44688f7cad682c44567a63a652fd0aefc38
doc_id: 60558
cord_uid: jjm9gz8i

Platelet indices are inexpensive, easily accessible parameters and potentially useful prognostic indicators in sepsis. In this study we explore the differences in platelet indices and their kinetics between sepsis survivors and non-survivors. A retrospective cohort-study of 97 cases of culture-positive sepsis at a tertiary-care center in North India. Demographics, clinical and laboratory parameters at admission were assessed. Platelet count (PLT), mean-platelet-volume (MPV), platelet-distribution-width (PDW) and plateletcrit (PCT) on admission, and third, fifth and last days of hospitalization were analyzed. Fractional change in platelet indices (ΔMPV(72h,) ΔPDW(72h), ΔPCT(72h), and ΔPLT(72h)) by day-3 were calculated. Unpaired and paired t-tests were used to compare survivors with non-survivors, and to study the change in platelet indices with time. Logistic regression was used for multivariate analysis. ROC-curves and optimum cut-offs to predict mortality were obtained. There were 64 survivors. Non-survivors had significantly higher ΔMPV(72h,) ΔPDW(72h,) day-1 MPV and PDW, and lower ΔPLT(72h). MPV and PDW increased, and PLT decreased with time among non-survivors. Trends were reversed in survivors. Only MPV and PDW showed significant change by day-3. Both were independent predictors of mortality on multivariate analysis, alongside ΔMPV(72h) and ΔPLT(72h). On ROC analysis, MPV, PDW, ΔMPV(72h,) ΔPDW(72h) and ΔPLT(72h) effectively predicted mortality. Cut-off for MPV was 10.25 fL (sensitivity = 93.9%, specificity = 60.9%), and PDW, 12.6% (sensitivity = 84.8%, specificity = 51.6%). A rise in MPV and a fall in PLT was associated with mortality in this study. MPV and PDW values at admission are effective predictors of mortality and may be used in conjunction with traditional parameters.

Sepsis is a constellation of various pathophysiological abnormalities that occurs due to a deleterious host response to infection, and eventually progresses to severe organ dysfunction, hypotension, septic shock, and death [1, 2] . A major cause of morbidity and mortality in India and worldwide, it is a dreaded clinical entity met with continuous developments in diagnostics and therapeutics [3] [4] [5] . Sepsis and septic shock are driven by inflammatory responses to microbial components; activation of cytokine cascades, leukocyte induced damage, endothelial injury, peripheral vasodilation, and disseminated intravascular coagulation [6] . Lactate is a well-known marker of anaerobic metabolism and predicts sepsis mortality [7, 8] . Likewise, procalcitonin levels are upregulated in sepsis by microbial toxins and effectively predict mortality [9] . Both these parameters are among the most routinely used in clinical practice.

The utility of inflammatory markers in sepsis such as interleukin-6, pentraxin-3, and simpler hematological markers like immature neutrophil ratios and neutrophillymphocyte ratio (NLR) has been documented previously [10] [11] [12] . Pro-inflammatory cytokines in sepsis increase tissue factor production and induce a procoagulant state.

Markers such as fibrinogen, prothrombin time, and antithrombin activity have been utilized to describe coagulopathy in sepsis [13, 14] . Platelets have been described as 'critical key players' in sepsis, affecting outcomes through platelet-endothelial cell interactions and leading to sequential organ failure [15] . Platelet indices include the platelet distribution width (PDW), which increases during accelerated platelet turnover; the mean platelet volume (MPV), indicative of platelet size; and plateletcrit (PCT), a measure of total platelet mass. These are inexpensive, easily accessible parameters available on a complete hemogram, but remain underutilized [16] .

Although platelet indices have been described for their prognostic utility in sepsis and septic shock, there is a relative scarcity of literature on the same. Findings from previous studies on MPV have been largely inconsistent. Some studies show higher MPV levels in non-survivors, whereas others establish the reverse [17] [18] [19] [20] . In this study, we analyze the kinetics of platelet indices in patients with sepsis. We also compare platelet indices at the time of admission between survivors and non-survivors and determine appropriate cut-offs for predicting mortality.

This retrospective cohort study was conducted at a tertiarycare center in North India. Patient records of 97 cases of sepsis between January and August 2020 were analyzed.

Sepsis was defined as per the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [1] . Records of adult patients admitted to the intensive care unit (ICU) who had blood-culture confirmed sepsis were evaluated. Recovered patients discharged from the ICU were placed in the survivor cohort, and those who succumbed, in the non-survivor cohort. Pregnant women, lactating mothers, patients who expired within five days of admission, patients who received platelet transfusions or fresh frozen plasma, and patients for whom investigations for all platelet indices were unavailable were excluded from the analysis. Patients with hematological malignancies, hypersplenism, immune thrombocytopenic purpura, reactive thrombocytosis, or essential thrombocythemia were also excluded.

Demographic information collected included patient age, sex, and the presence of comorbid conditions. The primary site of infection was noted. Complete hemogram parameters obtained on admission and the third, fifth, and last day of ICU stay were studied. These consisted of red cell counts (RBC), hemoglobin (Hb), total and differential leukocyte counts (TLC and DLC), NLR, and platelet indices, including platelet count (PLT), MPV, PDW, and PCT. Blood was collected in appropriate vacutainers using a closed draw vacuum system. Samples were not subjected to storage, and investigations were reported within 1.5 h. Cell counts were estimated using the Sysmex Ò KX-21 (Sysmex Corp, Japan) cell counter. All samples were subjected to a concomitant smear examination as well. Clinical parameters on admission, including vitals, routine investigations including renal and liver function tests, arterial blood gases, lactate levels, the need for ventilator support, an associated surgical intervention, and microbiological reports were also analyzed. Procalcitonin level on admission was estimated using VIDAS Ò B.R.A.H.M.S PCT (Biomérieux, France).

The normal reference intervals for the platelet parameters were; PLT (150-400 9 10 3 /uL), MPV (6.5-12.0 fL), PDW (9.0-17.0%) and PCT (0.15-0.38%). The fractional change in the MPV from the 1st day (on admission) to the 3rd day was calculated as DMPV 72h = (MPV on day-3-MPV on day-1) 7 (MPV on day-1). A similar treatment of the other platelet indices was used to obtain DPDW 72h , DPCT 72h , and DPLT 72h.

Statistical analysis was performed using SPSS 21.0 for Windows (Armonk, NY: IBM Corp). Continuous variables are expressed as mean ± standard deviation (SD) or medians with interquartile range (IQR), and categorical variables as percentages. Normality assumptions were tested using the Shapiro-Wilk test, and the homogeneity of variances assumption was tested using Levene's test. We used a paired-samples t-test to assess the change in platelet indices with time compared to the values on admission, and an independent-samples t-test to compare parameters between the survivor and non-survivor cohorts. Non-parametric variants of tests were used where appropriate. Association between categorical variables was assessed using the Chi-square test or Fisher's exact test. Binary logistic regression was used for multivariate analysis of platelet indices and other variables for predicting mortality. Receiver operator characteristic (ROC) curves were plotted to study the utility of different parameters as mortality predictors. Optimal cut-offs with sensitivity, specificity, and positive and negative predictive values (PPV and NPV) are reported. All p values \ 0.05 were considered statistically significant.

A total of 97 patients, comprising 64 (65.98%) survivors and 33 (34.02%) non-survivors, were studied. Baseline parameters at the time of admission were comparable between survivors and non-survivors (Table 1) . Comorbid conditions observed included type-2 diabetes mellitus, hypertension, coronary artery disease (CAD), or a combination of these, present in 48 patients. Hypertension was Indian J Hematol Blood Transfus present in 14, diabetes in 12, and CAD in 6 patients. Both diabetes and hypertension were present in 6, diabetes and CAD in 3, and hypertension and CAD in 3 patients. All three conditions were present in 4 patients.

Procalcitonin, lactate, MPV, and PDW values were significantly higher among non-survivors at admission. DMPV 72h , DPDW 72h , and DPCT 72h values were negative in survivors and positive in non-survivors, and conversely, DPLT 72h was positive in survivors and negative in non-survivors. Only DMPV 72h , DPDW 72h , and DPLT 72h showed a statistically significant difference between the two cohorts. No differences were observed for PLT, PCT, and NLR values at admission ( Table 2) .

Platelet indices on the third, fifth, and last day of hospitalization were compared with baseline values (day-1) using a repeated measures design ( Table 3 ). The time trends of these parameters for the survivor and non-survivor cohorts are represented graphically in (Fig. 1 ). Binary logistic regression was used to assess platelet indices, patient age, and comorbid conditions as mortality predictors (Table 4) . On multivariate analysis, MPV and PDW were significant predictors of mortality. Among platelet kinetics, DMPV 72h and DPLT 72h were independent predictors of mortality on adjusting for patient age and comorbid conditions. ROC curves for procalcitonin, lactate, MPV, PDW, DMPV 72h , DPDW 72h , and DPLT 72h were constructed (Fig. 2 ). Procalcitonin and lactate had the highest AUCs (0.909 and 0.877, respectively). MPV was the third-best mortality predictor, with an AUC = 0.825 and an optimum cut-off of 10.25 fL with a sensitivity of 93.9% and specificity of 60.9%. Other parameters showed moderate AUC values. The results are summarized in (Fig. 2 ).

Platelet indices vary significantly between sepsis survivors and non-survivors on admission. A distinct pattern of change in these parameters was observed during the clinical course of sepsis, which may have important clinical implications. Most notably, the MPV was significantly higher amongst non-survivors on admission, consistently increased with time in this group, and decreased among survivors. A higher MPV is indicative of increased platelet turnover by the bone marrow in response to stress, and smaller platelets are suggestive of platelet maturity. Younger, larger platelets are also functionally more active. With increased platelet activation in septic patients, [21] [22] [23] .

Previous studies have found elevated MPV levels in sepsis non-survivors, which return to normal after one week of effective antibiotic therapy [17, 18, 24] . Presumably, a high MPV is an indicator of an active and invasive systemic infection. Conflicting evidence exists regarding MPV in sepsis, with some studies reporting a lower level of MPV in non-survivors [19, 20] . Others propose more complex patterns of MPV changes-an initial rise of MPV in septicemia and a subsequent fall in sustained bacterial infections [25] . Our study demonstrates that a high and rising MPV is associated with severity and poor outcomes, and is valuable for dynamic prognostication of sepsis.

PDW changes paralleled MPV in this study, albeit to a moderate degree. The PDW values at admission were significantly higher among non-survivors and increased further with time. A high PDW indicates platelet heterogeneity, resulting from platelet swelling in the circulation and platelet immaturity. This finding is in agreement with other studies [17, 26, 27] . Both PLT and PCT did not vary significantly between survivors and non-survivors on Cox-Snell R 2 = 0.292; Nagelkerke R 2 = 211.

Indian J Hematol Blood Transfus admission but showed predictable time trends. PLT counts decreased over time in non-survivors, and both PLT and PCT values improved over time among survivors. Thrombocytopenia due to diminished production or increased turnover is a well-recognized consequence of sepsis, leading to hemorrhagic complications that arise from the consumption of platelets and coagulation factors. Persistent thrombocytopenia is associated with worse outcomes, and a single initial platelet count does not discriminate survivors from non-survivors [28, 29] . NLR at admission did not vary significantly between survivors and non-survivors but differed significantly on Day-5 and increased among non-survivors with disease progression. The NLR is a simple marker of systemic inflammation and stress, and a previous study has similarly described Day-5 NLR as a late phase mortality indicator of sepsis, but Day- 1 NLR was not significant [12] . Early phase predictors of mortality have greater clinical utility. These findings suggest that NLR does not change significantly at the onset of sepsis, showing detectable changes only later in the disease course. Lactate and procalcitonin values varied significantly between the two cohorts in our study. Lactate level rises following tissue hypoperfusion and anaerobic metabolism and is a fundamental danger sign in sepsis [7, 8] . Procalcitonin is a useful marker for both risk-stratification and prognostication in sepsis, which helps in guiding antibiotic use [9, 30] . Interestingly, we found that procalcitonin had a slightly higher AUC than lactate in this study. This is perhaps explained by the inclusion of only blood-culture positive patients with sepsis in our study [31] .

We constructed ROC curves to compare platelet indices, procalcitonin and lactate in predicting mortality. After lactate and procalcitonin (AUC = 0.877 and 0.909), MPV (AUC = 0.825) was the next best parameter with an optimum cut-off of 10.25 fL. The sensitivity was 93.9%, which was higher than that of both procalcitonin (81.8%) and lactate (69.7%). A previous study on a cohort of septic shock patients reported a cut-off of 10.5 fL for MPV [17] . Another reports a cut-off of 8.0 fL for the diagnosis of sepsis versus non-septic controls [19] . PDW had a moderate AUC = 0.634, with an optimum cut-off of 12.6%, and a sensitivity of 84.8%. However, both MPV and PDW had relatively poor specificities and PPV compared to lactate and procalcitonin. Interestingly, most patients in our study had MPV and PDW values in the normal range on admission, and the average values of MPV and PDW among both survivors and non-survivors were within the physiological reference ranges. The same is true for the cut-off values of MPV and PDW discussed earlier. Despite no definitive deviation beyond the critical point, even nuanced variations in these parameters predicted mortality. It may hence be prudent to consider the time-trends of platelet indices for monitoring patients of sepsis, as conventional reference ranges may be unsuitable.

Previous studies have emphasized the significance of the kinetics of platelet indices, especially over the first 72 h following admission [32, 33] . We calculated DMPV 72h, DPDW 72h , DPCT 72h , and DPLT 72h , which indicated the fractional change in platelet indices over the first three days of admission. DMPV 72h, DPDW 72h , and DPLT 72h varied significantly between survivors and non-survivors, and all three had moderate AUC values on ROC analysis. The optimum cut-off for DPDW 72h was 0.0215, which implies that an increase in PDW by more than 2.15% over the first 72 h favored mortality. The cut-offs for DPLT 72h and DMPV 72h had a negative sign and were 0.025 and 0.053, respectively. A fall in the PLT greater than 2.5% in the first 72 h was associated with an increased risk of mortality.

Similarly, an MPV value that did not decrease by at least 5.3% over the first 72 h increased the risk of mortality. In conjunction with early markers, monitoring the change in platelet indices over time, particularly over the first few days of admission, provides unique insight into the prognosis of sepsis.

Platelet indices are easily accessible hematology investigations that are routinely available in all complete hemogram reports. They are inexpensive and require small sample volumes and time for estimation, making them ideal for low-resource settings. Changes in platelet indices over time are easily estimated using simple arithmetic. The use of sophisticated assays may not always be feasible, creating undue strain on the healthcare system, especially when repeat serial measurements are required. Simple, cost-effective hematological markers, therefore, assume great significance.

Sepsis mortality and platelet indices are closely associated, but this study does not fully elucidate any underlying cause-effect relationships. Individual therapeutic decisions for each patient have implications on outcomes that could not be investigated. As this was a retrospective study, several factors could be out of the authors' control and subject to inconsistencies. Long-term survival outcomes and 28-day mortality data of patients in this study could not be analyzed. A prospective study design enables more complete and meticulous data collection and management. Prospective studies on larger patient populations are needed to adjust for all possible confounding variables more robustly.

Platelet indices are inexpensive, easily accessible parameters that may be useful prognostic indicators in sepsis. A rise in MPV, PDW, and a fall in PLT was associated with mortality in this study. An MPV of [ 10.25 fL and PDW [ 12.6% at admission were effective predictors of mortality.

Ethics Approval This retrospective study was conducted according to the principles of the Declaration of Helsinki. The study was approved by the scientific review committee and ethics committee of the institution (No. 1156/IEC/07/2020/18, dated 31 st July 2020).

Availability of Data Raw data used in the analysis will be made available on request.

Consent to Participate and for Publication In view of the retrospective nature of the study, patient consent was not needed.

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock

Epidemiology of adult-population sepsis in India: a single center 5 year experience

Severe sepsis epidemiology: sampling, selection, and society

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

The pathophysiology and treatment of sepsis

Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock

Blood lactate levels cutoff and mortality prediction in sepsis-time for a reappraisal? a retrospective cohort study

Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study

Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions

Significance of Hematological Scoring System (HSS) in early diagnosis of neonatal sepsis

Diagnostic and prognostic role of Neutrophil-to-Lymphocyte Ratio in early and late phase of sepsis

Significance of plasma fibrinogen level and antithrombin activity in sepsis: a multicenter cohort study using a cubic spline model

Role of plasma fibrinogen in diagnosis and prediction of short term outcome in neonatal sepsis

Platelets are critical key players in sepsis

Platelet volume: laboratory measurement and clinical application

The impact of various platelet indices as prognostic markers of septic shock

An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients

Effect of severe sepsis on platelet count and their indices

Mean platelet volume trend in sepsis: is it a useful parameter

Platelet aggregation in severe sepsis

Platelets in sepsis: an update on experimental models and clinical data

Platelet function in sepsis

Increased mean platelet volume in septicaemia

Mean platelet volume changes in infection

An investigation of the effects of the mean platelet volume, platelet distribution width, platelet/lymphocyte ratio, and platelet counts on mortality in patents with sepsis who applied to the emergency department

The effects of different infectious organisms on platelet counts and platelet indices in neonates with sepsis: is there an organism-specific response?

Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome

Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know

Role of procalcitonin use in the management of sepsis

Diagnostic value of procalcitonin in predicting bacteremia in intensive care unit

An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock

Platelet and mean platelet volume kinetics in adult patients with sepsis